The Trouble with Zyprexa
The Carlat Psychiatry Report, Volume 1, Number 2, February 2003
https://www.thecarlatreport.com/newsletter-issue/tcprv1n2/
From The Carlat Psychiatry Report, February 2003, Atypical Antipsychotics in Clinical Practice
Issue Links: | Editorial Information
Daniel Carlat, MD
Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Zyprexa (olanzapine) became rapidly popular after its introduction in the United States in 1996. Its structural similarity to Clozaril (clozapine) led to hopes that it would be as effective for treatment-resistant cases as Clozaril but without the risk of agranulocytosis.
You can't view details of this content, please login or buy subscription here